Faced with the challenges posed by multiple sclerosis (MS), many patients seek complementary solutions to improve their daily lives. Among these, CBD —a compound extracted from medical cannabis —is attracting increasing attention for its potential benefits. Let's explore together how CBD could be an additional asset in managing MS-related symptoms.
What is multiple sclerosis and why should you be interested in CBD?
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system , causing motor, sensory, or cognitive impairments. This condition often progresses in relapses, and its symptoms vary significantly from one patient to another. Conventional treatments can slow the progression but sometimes struggle to alleviate all the daily discomfort.
Given the diversity of symptoms and the complexity of MS, the use of medical cannabis in the treatment of multiple sclerosis is sometimes seen as a complementary approach. CBD, a non-psychoactive molecule derived from this plant, is particularly interesting for its potential to provide symptom relief without causing euphoria.
CBD and pain reduction related to MS
Pain is an integral part of the experience for many people living with multiple sclerosis . It can manifest as difficult - to-treat neuropathic pain or persistent muscle tension. Research has focused on how CBD affects these debilitating symptoms .
According to several clinical studies, CBD has shown an ability to regulate certain reactions of the nervous system, thus promoting pain reduction. By acting on endocannabinoid receptors, this component of medical cannabis helps to moderate pain signals transmitted to the brain.
- Can be used in conjunction with conventional treatment
- Reported decrease in the frequency and intensity of painful episodes
- Various forms available : oils, capsules , or topical solutions
What are the effects of CBD on spasticity and mobility in MS?
In addition to pain, reducing spasticity is crucial for preserving the independence of people with MS. Spasticity is an abnormal increase in muscle tone, leading to stiffness, involuntary contractions, and difficulty moving.
Research suggests that CBD , alone or in combination with other molecules derived from medical cannabis , contributes to muscle relaxation . This phenomenon may lead to improved mobility in some patients , or even a partial resumption of previously limited daily activities.
How does CBD contribute to reducing spasticity?
At the neurological level, CBD interacts with various circuits responsible for muscle contraction. Its ability to act indirectly on neurotransmitters could therefore facilitate a reduction in spasms and help relax excessively contracted muscles.
Themild anxiolytic effect reported by some users adds to this benefit, since nervous tension also tends to exacerbate spasticity. A more relaxed overall environment then facilitates motor recovery.
Can we observe a real improvement in mobility?
While each case remains unique, observations highlight a positive impact on agility and fluidity of movement. Some patients note increased ease in walking, standing up, or performing gentle exercises thanks to the reduction of muscle stiffness.
Here is some comparative data collected during evaluations of MS subjects taking CBD supplements :
| Symptom followed | CBD-free (%) | With CBD (%) |
|---|---|---|
| Persistent stiffness | 75 | 45 |
| Nocturnal spasms | 62 | 30 |
| Reduced mobility | 68 | 40 |
Neuroprotective, anti-inflammatory and antioxidant properties of CBD
Beyond its symptomatic effects CBDhas also been identified in studies neuroprotective properties of potential interest to the medical community. In multiple sclerosis (MS), inflammation gradually destroys myelin, the protective substance surrounding nerves. CBD possesses anti-inflammatory qualities that may limit this degradation.
The antioxidant properties of CBD also play a role. Oxidative stress accelerates neuronal damage. The supply ofantioxidants via medical cannabis therefore helps protect cells and improve overall brain tissue health.
- Observed effects on reducing inflammation around myelin sheaths
- Less progression of certain neurological damage reported in some animal
- Supply of natural compounds that strengthen cell protection
Frequently asked questions about CBD and multiple sclerosis
Does CBD cause undesirable side effects in patients with MS?
CBD is generally well tolerated , especially compared to other substances derived from medical cannabis . Some mild side effects are possible, such as temporary fatigue or slight dry mouth. Drug interactions may also occur; therefore, it is advisable to consult your doctor before use.
- Temporary fatigue
- Moderate digestive irritation
- Potential interactions with anticoagulant or sedative medications
In what forms can CBD be consumed to treat multiple sclerosis?
There are a variety of alternatives to suit individual preferences. Most commonly, you'll find oils, capsules, or softgels, and sometimes even creams designed for topical application to painful areas. The choice will depend on practicality, taste, and preferred method of administration.
- Sublingual oils
- Oral capsules
- Topical creams and balms
Is there solid scientific evidence regarding the effectiveness of CBD against MS?
Several publications point to a positive effect of CBD on pain reduction, spasticity reduction , andimproved mobility. However, further studies are needed to validate these results on a large scale and to define protocols adapted to all patient profiles.
| Indication | Quality of evidence |
|---|---|
| Pain reduction | Average to good according to pilot tests |
| Spasticity | Encouraging but still incomplete |
| Neuroprotection | Primarily demonstrated on animal models |
What dosage of CBD should be used by people with MS?
There is no universal dosage, as each body reacts differently. Current recommendations still favor a gradual start, with doses adjusted according to individual response. Medical supervision remains essential to ensure a safe and personalized approach.
- Start with small quantities
- Increase very gradually
- Monitor closely to adjust the dosage
Editor-in-Chief specializing in CBD
Julien, born on July 17, 1978, in the Paris region, is a prominent writer and expert in the field of CBD products. Following his studies, Julien developed a passion for natural remedies, including CBD. In 2022, he joined the CBD.fr team as an expert and regular contributor. Thanks to his scientific expertise and clear writing style, Julien helps demystify the complexities of CBD, while highlighting its benefits and potential applications through his articles and conference presentations.
